Matthew Tenorio - 03 Jan 2025 Form 4 Insider Report for EVERSPIN TECHNOLOGIES INC (MRAM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Jan 2025, 16:46:05 UTC
Prior SEC filing
03 Oct 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Cesare Suardi, Attorney-in-Fact for Matthew Tenorio

Key filing fact

Matthew Tenorio filed Form 4 for EVERSPIN TECHNOLOGIES INC (MRAM) on 06 Jan 2025.

Key facts

  • This page summarizes Matthew Tenorio's Form 4 filing for EVERSPIN TECHNOLOGIES INC (MRAM).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 06 Jan 2025, 16:46.

Change

  • Previous filing in this sequence was filed on 03 Oct 2024.
  • Current net transaction value: -$10,662.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MRAM transaction

Common Stock

Sale

Transaction value
$10,662
Shares
-1,695
Change %
-11%
Price
$6.29
Shares after
14,228
Date
03 Jan 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares sold solely to pay taxes due upon the vesting of Restricted Stock Units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .